Torrent obtains exclusive commercialization rights for Hanmi Pharm's lanreotide in the US market

老虎证券2026/04/21 07:29

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

According to the agreement, Hanyu Pharmaceutical will be responsible for the technical development and production supply of Lanreotide Acetate Long-acting Injection, while Torrent will obtain exclusive commercialization rights for this product in the US market. Lanreotide Acetate is a long-acting somatostatin analogue used to treat acromegaly and certain neuroendocrine tumors.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Torrent obtains exclusive commercialization rights for Hanmi Pharm's lanreotide in the US market

You may also like

Crypto prices